The cDC1s were shown to interact mainly with CD8+ T cells to induce potent CTL responses, while cDC2s can induce Th2 or Th17 responses, through presentation of tumor associated antigens (TAAs) on their MHC-II complexes (12, 94, 96). This evidence concerns the gene CD8A and neoplasm.